Please assess the completion status of the following clinical trial:

Trial Title: Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Newly diagnosed primary distant metastatic breast cancer (M1)~* Anticipated survival of at least 6 months~* Histologically proven breast cancer~* Hormonal and HER2Neu status should be known~* T1-T3, resectable T4 status, N0-N3~* Performance status of the patient should allow surgery / systemic therapy~* Co-morbidity of the patient should allow surgery / systemic therapy~* Age \> 18 years~* Written informed consent~Exclusion Criteria:~* Primary invasive breast cancer in medical history~* Other malignancy within the last 10 years, besides basal cell carcinoma of the skin or early stage cervical cancer~* Surgical treatment / radiotherapy of this breast tumor before randomization~* Irresectable T4 breast tumor~* Synchronous bilateral breast cancer

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Upfront surgery (Type: EXPERIMENTAL): Upfront surgery followed by systemic treatment
- Systemic therapy (Type: OTHER): Systemic therapy possibly followed by local treatment of the breast tumor

Based on this trial design, predict the completion outcome and termination type (if applicable).